- Author
- Tatiana A. Mishchenko, Victoria D. Turubanova, Ekaterina N. Gorshkova, Olga Krysko (UGent) , Maria V. Vedunova and Dmitri Krysko (UGent)
- Organization
- Abstract
- Immunogenic cell death (ICD) arouses great interest in targeting glioma, the most common primary brain tumor, to achieve boosted immunotherapy. We discuss the unexpected findings on the induction of Th17 immunity by ICD and propose the best design for dendritic cell (DC)-based vaccines loaded with whole glioma lysates obtained after ICD inducers.
- Keywords
- glioma, immunogenic cell death, glioma immunotherapy, DC vacccine, DC vaccination, tumor microenvironment, whole tumor lysates, Th17, cell death, glioblastoma, CNS, cancer
Downloads
-
(...).pdf
- full text (Published version)
- |
- UGent only
- |
- |
- 489.94 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01HTFFE4R83DRVGR5HA6XA0RAJ
- MLA
- Mishchenko, Tatiana A., et al. “Targeting Immunogenic Cell Death for Glioma Immunotherapy.” TRENDS IN CANCER, vol. 10, no. 1, 2024, pp. 8–11, doi:10.1016/j.trecan.2023.10.005.
- APA
- Mishchenko, T. A., Turubanova, V. D., Gorshkova, E. N., Krysko, O., V. Vedunova, M., & Krysko, D. (2024). Targeting immunogenic cell death for glioma immunotherapy. https://doi.org/10.1016/j.trecan.2023.10.005
- Chicago author-date
- Mishchenko, Tatiana A., Victoria D. Turubanova, Ekaterina N. Gorshkova, Olga Krysko, Maria V. Vedunova, and Dmitri Krysko. 2024. “Targeting Immunogenic Cell Death for Glioma Immunotherapy.” TRENDS IN CANCER. https://doi.org/10.1016/j.trecan.2023.10.005.
- Chicago author-date (all authors)
- Mishchenko, Tatiana A., Victoria D. Turubanova, Ekaterina N. Gorshkova, Olga Krysko, Maria V. Vedunova, and Dmitri Krysko. 2024. “Targeting Immunogenic Cell Death for Glioma Immunotherapy.” TRENDS IN CANCER. doi:10.1016/j.trecan.2023.10.005.
- Vancouver
- 1.Mishchenko TA, Turubanova VD, Gorshkova EN, Krysko O, V. Vedunova M, Krysko D. Targeting immunogenic cell death for glioma immunotherapy. Vol. 10, TRENDS IN CANCER. 2024. p. 8–11.
- IEEE
- [1]T. A. Mishchenko, V. D. Turubanova, E. N. Gorshkova, O. Krysko, M. V. Vedunova, and D. Krysko, “Targeting immunogenic cell death for glioma immunotherapy,” TRENDS IN CANCER, vol. 10, no. 1. pp. 8–11, 2024.
@misc{01HTFFE4R83DRVGR5HA6XA0RAJ,
abstract = {{Immunogenic cell death (ICD) arouses great interest in targeting glioma, the most common primary brain tumor, to achieve boosted immunotherapy. We discuss the unexpected findings on the induction of Th17 immunity by ICD and propose the best design for dendritic cell (DC)-based vaccines loaded with whole glioma lysates obtained after ICD inducers.}},
author = {{Mishchenko, Tatiana A. and Turubanova, Victoria D. and Gorshkova, Ekaterina N. and Krysko, Olga and V. Vedunova, Maria and Krysko, Dmitri}},
issn = {{2405-8033}},
keywords = {{glioma,immunogenic cell death,glioma immunotherapy,DC vacccine,DC vaccination,tumor microenvironment,whole tumor lysates,Th17,cell death,glioblastoma,CNS,cancer}},
language = {{eng}},
number = {{1}},
pages = {{8--11}},
series = {{TRENDS IN CANCER}},
title = {{Targeting immunogenic cell death for glioma immunotherapy}},
url = {{http://doi.org/10.1016/j.trecan.2023.10.005}},
volume = {{10}},
year = {{2024}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: